Pr Duygu Övünç Hacıhamdioğlu

Formation et Spécialisation

• 1994–2000 Académie de Médecine Militaire de Gülhane, Faculté de Médecine
• 2003–2007 Faculté de Médecine GATA – Spécialisation en Pédiatrie
• 2010–2013 Faculté de Médecine GATA – Formation de Surspécialité en Néphrologie Pédiatrique

Expérience Professionnelle

• 2001–2003 Caserne de Gendarmerie Eşref Bitlis, Ankara
• 2008–2009 Caserne de Gendarmerie Eşref Bitlis, Ankara
• 2013–2015 Hôpital de Formation GATA Haydarpaşa
• 2015–2016 Hôpital de la Faculté de Médecine de l’Université de Maltepe
• 2016–2017 Université des Sciences de la Santé, Hôpital de Formation et de Recherche Süleymaniye en Maternité et Maladies Pédiatriques
• Depuis le 19.09.2017 BAU Medical Park Göztepe

Affiliations Professionnelles

• Société Turque de Néphrologie Pédiatrique
• Association Turque de Néphrologie
• Société Européenne de Néphrologie Pédiatrique (ESPN)
• Chambre des Médecins d’Istanbul

• 1.Kısmet E., Köseoglu V., Demirkaya E., Gülgün M., Hacıhamdıoglu D.Ö., Demırbag S. ‘Wilms tumor associated with elevated alpha-fetoprotein level.’  Pediatric Blood & Cancer, 44(4), 423-424. (2005).
• 2.Kendırlı T., Aydın HI.Hacıhamdıoglu D.Ö., Gülgün M., Ünay B., Akın R., Lenk MK., Gökçay E.  ‘Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.’ Journal of Hospital Infection, 56(4),328, (2004).
• 3.Hacıhamdıoglu B.,Ünay B.,Hacıhamdıoglu D.Ö., Vurucu S., Akın R. ‘Goldenhar syndrome with duodenal atresia: a new finding.’  Clinical Dysmorphology, 17(2), 141-142., (2008).
• 4. Hacıhamdıoglu D.Ö., Özen S. ‘Canakinumab induces remission in a patient with resistant familial Mediterranean fever’. Rheumatology, 51(6), 1041-1041. (2012).
• 5.Hacıhamdıoglu D.Ö., Kürekci A.E., Gürsel O.,  Atay A.A., Balamtekin N., Aydın A., Hasimi A., Özcan O. ‘Evaluation of lipid peroxidation and antioxidant system in healthy iron-replete infants receiving iron prophylaxis.’  Nutrition, 29(1),138-142. (2013).
• 6.Hacıhamdıoglu D.Ö., Fidancı K., Kılıç A., Gök F., Topaloglu R. ‘QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study.’ Pediatric Nephrology, 28(10), 1969-1974. (2013).
• 7.Svjetlana,Fang Humphrey,Song Xuewen,Cattran Daniel C,Avila Casado Carmen,Paterson AndrewD,Nitschk Patrick,Bole Feysot Christine,Cochat Pierre,Esteve Rudd Julian,Haberberger Birgit,AllenSusan J,Zhou Weibin,Airik Rannar,Otto Edgar A,Barua Moumita,Al Hamed Mohamed H,KariJameela A,Evans Jonathan,Bierzynska Agnieszka,Saleem Moin A,Böckenhauer Detlef,Kleta Robert, El Desoky Sherif,Hacıhamdıoglu Duygu Övünç,Gök Faysal,Washburn Joseph,Wiggins Roger C,Choi Murim,Lifton Richard P,Levy Shawn,Han Zhe,Salviati Leonardo,Prokisch Holger,Williams David S,Pollak Martin,Clarke Catherine F,Pei York,Antignac Corinne,Hildebrandt Friedhelm ‘ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis  disruption’. Journal of Clinical Investigation, 123(12), 5179-5189., (2013). 
• 8.Hacıhamdıoglu D.Ö., Demırız M., Sobacı G., Kocaoglu M., Demirkaya E., Gök F. ‘Cerebral vein thrombosis in a four year old with Behçet's disease.’ Reumatología Clínica (English Edition), 10(4), 254-256., (2014).
• 9.Hacıhamdıoglu D.Ö., Aydemır G., Meral C., Kul M., Karademır  F., Süleymanoglu S. ‘Cyclosporin A-induced posterior reversible encephalopathy syndrome in an adolescent with steroid-resistant nephrotic syndrome’. International Urology and Nephrology, 46(10), 2055-2056., (2014).
• 10.Altun D., Kürekci A.E., Gürsel O., Hacıhamdıoglu D.Ö., Kurt I., Aydın A., Özcan O. ‘Malondialdehyde, Antioxidant Enzymes, and Renal Tubular Functions in Children with Iron Deficiency or Iron-Deficiency Anemia’. Biological Trace Element Research, 161(1), 48-56., (2014). 
• 11.Hacıhamdıoglu D. Ö., Hacıhamdıoglu B., Aydemır G., Kul M., Karademır F., Süleymanoglu S.  ‘Mannitol Induced Acute Kidney Injury During Treatment of Cerebral Edema Due to Diabetic Ketoacidosis in an Adolescent’. Nobel Medicus, 11(2), 93-96. (2015).
• 12.Hacıhamdıoglu B., Hacıhamdıoglu D. Ö., Delıl K. ‘22q11 deletion syndrome: current perspective.’ The Application of Clinical Genetics, 8, 123-132. (2015)
• 13.Hacıhamdıoglu D. Ö., Zeybek C., Gök F., Pekel A., Musabak U.H.’Elevated Urinary T Helper 1 Chemokine Levels in Newly Diagnosed Hypertensive Obese Children’. Journal of Clinical Research in Pediatric Endocrinology, 7(3), 175-182. (2015)
• 14.Hacıhamdıoglu D.Ö., Düzova A.,Alehan D., Oguz B.,Besbas N. ‘Circulating fibroblast growth factor 23 in children on peritoneal dialysis is associated with effective dialysis.’ Turkish Journal of Pediaatrics, 57(1), 9-16. (2015).
• 15. Hacıhamdioğlu D.Ö., Hacıhamdioğlu B, Altun D, Müftüoğlu T, Karademir F, Süleymanoğlu S. ‘Urinary Netrin-1: A New Biomarker for the Early Diagnosis of Renal Damage in Obese’. Children. J Clin Res Pediatr Endocrinol. Sep 1;8(3):282-7. (2016)
• 16. Hacıhamdioğlu D.Ö., Altun D, Hacıhamdioğlu B, Çekmez F, Aydemir G, Kul M, Müftüoğlu T, Süleymanoğlu S, Karademir F.  ‘The Association between Serum 25-Hydroxy Vitamin D Level and Urine Cathelicidin in Children with a Urinary Tract Infection.’ J Clin Res Pediatr Endocrinol. Sep 1;8(3):325-9. (2016)
• 17. Montini G, Busutti M, Yalcinkaya F, Woolf AS, Weber S; Alpay H, Ariceta G, Bael A, Bonthuis M, Caliskan S, Gotsiridze E, Gulleroglu K, Gunduz Z, Hacihamdioglu DO, Hoefele J, Ismaili K, Jardim H, Maringhini S, Montini G, Murer L, Ozcakar B, Parvex P, Paunova S, Antic AP, Raes A, Rtskhiladze I, Schurmans T, Sever FL, Tasic V, Tullus K, Van Eerde A, Weber S, Woolf AS, Yalcinkaya F, Yildiz N, Yilmaz A, Yuksel S, Zaniew M. European Society for Paediatric Nephrology Working Group on Congenital Anomalies of the Kidney and Urinary TractJ A questionnaire survey of radiological diagnosis and management of renal dysplasia in children. Nephrol. 2018 Feb;31(1):95-102.